Hypertension and coronary heart disease

被引:87
|
作者
Escobar, E [1 ]
机构
[1] Univ Chile, Santiago, Chile
关键词
hypertension; hypertrophy; coronary heart disease;
D O I
10.1038/sj.jhh.1001345
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The association of hypertension and coronary heart disease is a frequent one. There are several pathophysiologic mechanisms which link both diseases. Hypertension Induces endothelial dysfunction, exacerbates the atherosclerotic process and it contributes to make the atherosclerotic plaque more unstable. Left ventricular hypertrophy, which is the usual complication of hypertension, promotes a decrease of 'coronary reserve' and increases myocardial oxygen demand, both mechanisms contributing to myocardial ischaemia. From a clinical point of view hypertensive patients should have a complete evaluation of risk factors for atherosclerosis, damage of arterial territories other than the coronary one, and of the extension and severity of coronary artery involvement. It is important to emphasise that complications and mortality of patients suffering a myocardial infarction are greater in hypertensive patients. Treatment should be aimed to achieve optimal values of blood pressure, and all the strategies to treat coronary heart disease should be considered on an individual basis.
引用
收藏
页码:S61 / S63
页数:3
相关论文
共 50 条
  • [41] Prevalence and correlates of coronary heart disease and hypertension in bipolar I disorder
    Goldstein, B. I.
    Houck, P. R.
    Fagiolini, A.
    BIPOLAR DISORDERS, 2009, 11 : 43 - 44
  • [42] Psychosocial factors and progression from prehypertension to hypertension or coronary heart disease
    Player, Marty S.
    King, Dana E.
    Mainous, Arch G., III
    Geesey, Mark E.
    ANNALS OF FAMILY MEDICINE, 2007, 5 (05) : 403 - 411
  • [43] Effects of percutaneous coronary intervention on the ambulatory blood pressure of patients with hypertension and coronary heart disease
    Jing Yang
    Xuming Yang
    Wei Liu
    Tingting Cao
    Irish Journal of Medical Science (1971 -), 2015, 184 : 845 - 850
  • [44] Endothelial dysfunction and prognosis after coronary interventions in patients with coronary heart disease and arterial hypertension
    Kazak, M. V.
    Sukhovey, N. A.
    Omelyanenko, M. G.
    Tomilova, I. K.
    Aleksakhina, E. L.
    Plekhanov, V. G.
    Romanchuk, S. V.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2011, 10 (05): : 30 - 36
  • [45] Effects of percutaneous coronary intervention on the ambulatory blood pressure of patients with hypertension and coronary heart disease
    Yang, Jing
    Yang, Xuming
    Liu, Wei
    Cao, Tingting
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 (04) : 845 - 850
  • [46] The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension study
    Ekstrom, Mattias
    Hellman, Anna
    Hasselstrom, Jan
    Hage, Camilla
    Kahan, Thomas
    Ugander, Martin
    Wallen, Hakan
    Persson, Hans
    Linde, Cecilia
    ESC HEART FAILURE, 2020, 7 (02): : 737 - 746
  • [47] Exploring the Relationship Between Different Obesity Metabolism Indices and Hyperuricemia in Patients with Hypertension and Coronary Heart Disease
    Li, Yuanyuan
    Yi, Shanting
    Jiang, Wencai
    Gong, Meihui
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 3817 - 3832
  • [48] The value of nifedipine in the treatment of hypertension, coronary heart disease and myocardial infarction (post-infarction therapy)
    Schulz, J
    Schmidt, J
    Ruck, W
    CURRENT MEDICAL RESEARCH AND OPINION, 1996, 13 (07) : 397 - 408
  • [49] 25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension - Is it worth the "hype"?
    Michos, Erin D.
    Lutsey, Pamela L.
    ATHEROSCLEROSIS, 2016, 245 : 237 - 239
  • [50] Triglyceride-glucose index as a marker of adverse cardiovascular prognosis in patients with coronary heart disease and hypertension
    Liu, Yahui
    Zhu, Binbin
    Zhou, Weicen
    Du, Yao
    Qi, Datun
    Wang, Chenxu
    Cheng, Qianqian
    Zhang, You
    Wang, Shan
    Gao, Chuanyu
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)